Latest Report Available at Orbis research Predictive
and Presymptomatic Testing Market provides pin-point analysis for changing
competitive dynamics and a forward looking perspective on different factors
driving or restraining industry growth.
Request sample
copy of this report @ http://www.orbisresearch.com/contacts/request-sample/219612 .
Genetic testing and screening is the next big thing in the area of
molecular diagnostics. Advances in accuracy and steady market growth in genetic
testing are opening a number of exciting new doors when it comes to
understanding, predicting and eventually treating disease. Today, there are
over 2000 clinical tests available to test various monogenetic diseases or
acquired chromosomal disorders. The genetic testing market can be fragmented to
three broad segments - diagnostic testing, relationship testing and predictive
testing.
Of this Predictive testing is acquiring great interest as screening technique for individuals.
Predictive and presymptomatic testing is utilized for the detection of
gene mutations that are related to disorders appearing after birth, frequently
in later stages of life. Such tests can be of assistance to individuals having
a family member with a genetic disorder, though they are free of any features
themselves of the disorder while testing. Predictive testing can aid in the
identification of mutations that can increase an individuals possibilities of
developing disorders as in the case of specific cancers.
Globally, the market for predictive & presymptomatic testing is
projected to reach US$5.7 billion by 2020 and North America is set to be the
highest grossing market closely followed by Europe.
Browse Complete
Report @ http://www.orbisresearch.com/reports/index/global-predictive-and-presymptomatic-testing-market-industry-analysis-and-market-forecast-2017-2022 .
Some points from TOC:
1. Introduction
2. Global Predictive and Presymptomatic Testing Market
3. Difference from conventional medical testing
3.1 Individual versus family
3.1 Individual versus family
4. Commonly Tested Conditions
4.1 Multiple endocrine neoplasia type 2
4.2 Haemochromatosis
4.3 Colorectal cancer
4.4 Breast and ovarian cancer
4.5 Alzheimer's disease
4.1 Multiple endocrine neoplasia type 2
4.2 Haemochromatosis
4.3 Colorectal cancer
4.4 Breast and ovarian cancer
4.5 Alzheimer's disease
5 .Factors affecting utility
6. Possible Benefits of Predictive testing
7. Implications
8. DISCLAIMER
Purchase a copy of Predictive and Presymptomatic Testing
Market visit @ http://www.orbisresearch.com/contact/purchase/219612 For more information contact sales@orbisresearch.com .
About Us:
Orbis Research (orbisresearch.com) is a single point aid
for all your market research requirements. We have vast database of reports
from the leading publishers and authors across the globe. We specialize in
delivering customized reports as per the requirements of our clients. We have
complete information about our publishers and hence are sure about the accuracy
of the industries and verticals of their specialization. This helps our clients
to map their needs and we produce the perfect required market research study
for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214)
884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment